Novavax (NVAX) Intangibles (2013 - 2022)
Novavax (NVAX) recorded quarterly Intangibles of $8.5 million in Q3 2022, up 109.67% quarter-over-quarter from $4.0 million in Q2 2022, and up 68.21% on a YoY basis from $5.0 million in Q3 2021.
Novavax (NVAX) Intangibles (2013 - 2022) Analysis & Trends
Novavax's Intangibles history runs 10 years deep, the most recent figure standing at $8.5 million for Q3 2022.
- In Q3 2022, Intangibles rose 68.21% year-over-year to $8.5 million; the TTM figure through Sep 2022 stood at $8.5 million (up 68.21% YoY), while the FY2021 annual figure was $4.8 million, down 16.68% from the prior year.
- Intangibles was $8.5 million for Q3 2022 at Novavax, up from $4.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $8.5 million in Q3 2022 to a low of $4.0 million in Q2 2022.
- Historically, Intangibles has averaged $5.8 million across 5 years, with a median of $5.5 million in 2019.
- The sharpest annual moves came in 2018 and 2022: Intangibles retreated 27.21% in 2018, then surged 68.21% in 2022.
- A 5-year view of Intangibles shows it stood at $6.5 million in 2018, then declined by 14.68% to $5.6 million in 2019, then rose by 2.58% to $5.7 million in 2020, then dropped by 16.68% to $4.8 million in 2021, then jumped by 77.27% to $8.5 million in 2022.
- The last three Intangibles figures came in at $8.5 million (Q3 2022), $4.0 million (Q2 2022), and $4.5 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Novavax | 1.49 Bn | 931.98 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 8.46 Mn |
| Jun 30, 2022 | 4.03 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Sep 30, 2021 | 5.03 Mn |
| Jun 30, 2021 | 5.28 Mn |
| Mar 31, 2021 | 5.27 Mn |
| Dec 31, 2020 | 5.73 Mn |
| Sep 30, 2020 | 5.33 Mn |
| Jun 30, 2020 | 5.25 Mn |
| Mar 31, 2020 | 5.05 Mn |
| Dec 31, 2019 | 5.58 Mn |
| Sep 30, 2019 | 5.47 Mn |
| Jun 30, 2019 | 5.96 Mn |
| Mar 31, 2019 | 6.11 Mn |
| Dec 31, 2018 | 6.54 Mn |
| Sep 30, 2018 | 6.75 Mn |
| Jun 30, 2018 | 6.90 Mn |
| Mar 31, 2018 | 7.58 Mn |
| Dec 31, 2017 | 7.87 Mn |